/Gilead%20Sciences%2C%20Inc_%20logo%20and%20vials%20-by%20Melnikov%20Dmitriy%20via%20Shutterstock.jpg)
Valued at a market cap of $182.5 billion, Gilead Sciences, Inc. (GILD) is a Foster City, California–based biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines. The company addresses significant unmet medical needs, with a strong leadership position in HIV treatments and a growing presence in oncology and inflammatory diseases through its expanding pipeline.
Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and GILD fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the drug manufacturers - general industry. The company is known for its scientific innovation, strong clinical development capabilities, and focus on addressing high unmet medical needs, which positions it competitively within the industry.
